Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Shineway Pharmaceutical GroupCSWYY 88 Forward Rate of Return (Yacktman) % is 26.34% as of Dec. 2025, which is 147% above its 10-year median of 10.66. GuruFocus rates CSWYY with a GF Score™ of 88/100 and a GF Value™ of $15.61. The stock has 2 warning signs investors should review. Among 636 Drug Manufacturers companies, China Shineway Pharmaceutical Group ranks better than 95.91% on this metric.
Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. China Shineway Pharmaceutical Group's forward rate of return for was 26.34%.
The historical rank and industry rank for China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) % or its related term are showing as below:
CSWYY'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -4.23 Med: 10.66 Max: 30.15
Current: 26.94
During the past 13 years, China Shineway Pharmaceutical Group's highest Forward Rate of Return was 30.15. The lowest was -4.23. And the median was 10.66.
CSWYY's Forward Rate of Return (Yacktman) % is ranked better than 95.91% of 636
companies
in the Drug Manufacturers industry
Industry Median: 6.6
vs CSWYY: 26.94
Unlike the Earnings Yield %, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
China Shineway Pharmaceutical Group (OTCPK:CSWYY) Forward Rate of Return (Yacktman) % Explanation
Unlike the Earnings Yield, the Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is to make it comparable to the growth rate.
Be Aware
In the Forward Rate of Return calculation, the growth rate is added directly to today's free cash flow yield. Therefore the calculation is reliable only if the company can grow at the same rate in the future as it did in the past. Investors should pay close attention to this when researching growth stocks. A more accurate measurement for return is Return on Capital.
China Shineway Pharmaceutical Group Forward Rate of Return (Yacktman) % Related Terms
China Shineway Pharmaceutical Group Forward Rate of Return (Yacktman) % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group Forward Rate of Return (Yacktman) % Chart
CSWYY vs ZTS: Forward Rate of Return (Yacktman) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) %, along with its competitors' market caps and Forward Rate of Return (Yacktman) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Shineway Pharmaceutical Group Forward Rate of Return (Yacktman) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) % distribution charts can be found below:
* The bar in red indicates where China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) % falls into.
China Shineway Pharmaceutical Group Forward Rate of Return (Yacktman) % Calculation
Forward Rate of Return is a concept that Don Yacktman uses in his investment approach. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation. He said in the interview (March 2012, when the S&P 500 was at about 1400):
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Rate of Return (Yacktman) % of 26.34% mean?
China Shineway Pharmaceutical Group (CSWYY) has a Forward Rate of Return (Yacktman) % of 26.34% as of Dec. 2025. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on China Shineway Pharmaceutical Group and its competitors. This is 147% above median its historical median of 10.66. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #26 out of 636 companies in the Drug Manufacturers industry, placing it in the top 4.1%.
Is China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) % too high?
China Shineway Pharmaceutical Group's current Forward Rate of Return (Yacktman) % of 26.34% is 147% above median its 10-year median of 10.66. The Drug Manufacturers industry median Forward Rate of Return (Yacktman) % is 6.60. China Shineway Pharmaceutical Group's value of 26.34% is 299.1% above this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #26 out of 636 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's Forward Rate of Return (Yacktman) % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #26 out of 636 companies for Forward Rate of Return (Yacktman) %. This places China Shineway Pharmaceutical Group in the top 4% of its industry — outperforming the majority of peers. The industry median Forward Rate of Return (Yacktman) % is 6.60. China Shineway Pharmaceutical Group's value of 26.34% is 299.1% above this benchmark. While the company's 10-year median is 10.66 vs. the industry median of 6.60, China Shineway Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Rate of Return (Yacktman) % for a Drug Manufacturers company?
The median Forward Rate of Return (Yacktman) % among Drug Manufacturers companies is 6.60, based on 636 companies in the industry. Companies in the top quartile (top 25%) have a Forward Rate of Return (Yacktman) % significantly above this median, while those in the bottom quartile fall well below. However, Forward Rate of Return (Yacktman) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current Forward Rate of Return (Yacktman) % of 26.34% is 299.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Rate of Return (Yacktman) % mean?
A high Forward Rate of Return (Yacktman) % can signal that a stock is expensive relative to its fundamentals. Yacktman's forward rate of return equals the sum of normalized free-cash-flow yield plus earnings growth. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median Forward Rate of Return (Yacktman) % is 6.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current Forward Rate of Return (Yacktman) % is 26.34%, which is 147% above median its own 10-year median of 10.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current Forward Rate of Return (Yacktman) % of 26.34%. The stock's GF Value™ is $15.61, compared to a current price of $19.25 — trading 23.3% above its estimated fair value. The current Forward Rate of Return (Yacktman) % is 26.34%, which is 147% above median its 10-year median of 10.66 and 299.1% above the Drug Manufacturers industry median of 6.60. China Shineway Pharmaceutical Group's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Rate of Return (Yacktman) % calculated?
Forward Rate of Return (Yacktman) % is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current Forward Rate of Return (Yacktman) % is 26.34% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $19.25 is trading 23.3% above its estimated GF Value™ of $15.61.
Key valuation signals for CSWYY:
Forward Rate of Return (Yacktman) %: 26.34% (147% above median its 10-year median of 10.66)
GF Value™: $15.61 vs. price of $19.25 (23.3% above fair value)
Industry Position: 299.1% above the Drug Manufacturers median (#26 of 636)
No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
88GF Score
Get the complete analysis for CSWYY
Forward Rate of Return (Yacktman) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYY has been successfully added to your 
